Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.

Clinical trial NCT05116917 · TERMINATED

Trial details

NCT number: NCT05116917
Sponsor: Herlev Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2021-11-05
Primary completion: 2023-10-19
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.